# Prediction and analysis of components and functions of Ixeris chinensis based on network pharmacology and molecular docking

**Authors:** Ziwei Ni, Zhe Ma, Xiaoting Qiao, Yaqian Guo, Cailian Ruan, Yayun Wang, Ying Yang

PMC · DOI: 10.3389/fmed.2024.1360966 · Frontiers in Medicine · 2024-06-27

## TL;DR

This study uses network pharmacology and molecular docking to identify active components and potential disease targets of Ixeris chinensis, supporting its medicinal value and future drug development.

## Contribution

The study provides a comprehensive analysis of Ixeris chinensis's active ingredients, key targets, and signaling pathways using network pharmacology and molecular docking.

## Key findings

- 12 effective components and 40 key targets were identified, including AKT1, TNF, and EGFR.
- Molecular docking showed strong binding between active components and key targets.
- Meta-analysis confirmed Ixeris extract reduces blood lipid levels in animals.

## Abstract

It is reported that the Ixeris chinensis has high medicinal value, but there are few reports about its potential molecular mechanism. We used a network pharmacology approach to predict the active ingredients, targets of action and possible interventions in diseases of Ixeris chinensis.

We employed various databases and software to predict the active ingredients, target genes, protein interactions, signaling pathways, network diagrams, and molecular docking of Ixeris chinensis. Simultaneously, we searched multiple Chinese and English databases and conducted meta-analyses of five randomized controlled trials.

The analysis results revealed 12 effective components, including apigenin β-sitosterol, baicalin, baicalein, and luteolin; and selected 40 key targets, including AKT1, TNF, EGFR, ESR1, SRC, among others. GO analysis generated 225 biological processes, 39 cellular components, and 65 molecular functions; KEGG analysis revealed 103 signaling pathways. Molecular docking results indicated that the main active components of Ixeris chinensis can bind well with key targets. Five randomized controlled trials were included. Meta-analysis showed that Ixeris extract can effectively reduce animal blood lipid levels.

This study revealed the main active ingredients and key targets of Ixeris chinensis, analyzed the signaling pathways of potential targets, conducted disease prediction, and performed molecular docking prediction, providing a basis for research on the pathways of Ixeris treatment for related diseases and subsequent new drug development.

## Linked entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], TNF (tumor necrosis factor) [NCBI Gene 7124], EGFR (epidermal growth factor receptor) [NCBI Gene 1956], ESR1 (estrogen receptor 1) [NCBI Gene 2099], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714]
- **Chemicals:** apigenin (PubChem CID 5280443), β-sitosterol (PubChem CID 222284), baicalin (PubChem CID 64982), baicalein (PubChem CID 5281605), luteolin (PubChem CID 5280445)

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Chemicals:** lipid (MESH:D008055), apigenin (MESH:D047310), baicalin (MESH:C038044), Ixeris extract (-), luteolin (MESH:D047311), beta-sitosterol (MESH:C025473), baicalein (MESH:C006680)
- **Species:** Ixeris chinensis (species) [taxon 318058]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11236556/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11236556/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC11236556/full.md

---
Source: https://tomesphere.com/paper/PMC11236556